出典: meddic

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/01/08 21:02:27」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Chemoprevention for Breast Cancer.
  • Pruthi S1, Heisey RE, Bevers TB.
  • Annals of surgical oncology.Ann Surg Oncol.2015 Oct;22(10):3230-5. doi: 10.1245/s10434-015-4715-9. Epub 2015 Jul 23.
  • BACKGROUND: Many women at increased risk for breast cancer could benefit from preventive therapy. Preventive therapy options for breast cancer risk reduction have expanded in the last few years to include both selective receptor modulators (tamoxifen and raloxifene) and aromatase inhibitors (anastro
  • PMID 26202562
  • Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR(+)/HER2(-) Advanced Breast Cancer From a US Payer Perspective.
  • Xie J1, Hao Y2, Zhou ZY3, Qi CZ3, De G4, Glück S5.
  • Clinical breast cancer.Clin Breast Cancer.2015 Oct;15(5):e263-76. doi: 10.1016/j.clbc.2015.04.001. Epub 2015 Apr 23.
  • INTRODUCTION: The objective of the study was to assess the cost-effectiveness of EVE+EXE versus endocrine monotherapies in the treatment of postmenopausal women with HR(+), HER2(-) ABC after failure of treatment with nonsteroidal aromatase inhibitors from a US third-party payer perspective.MATERIALS
  • PMID 26048087
  • Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.
  • Speirs V1, Viale G2, Mousa K3, Palmieri C4, Reed SN3, Nicholas H3, Cheang M5, Jassem J6, Lønning PE7, Kalaitzaki E5, van de Velde CJ8, Rasmussen BB9, Verhoeven DM10, Shaaban AM11, Bartlett JM12, Bliss JM5, Coombes RC13; PathIES Sub-Committee.
  • Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2015 Sep;26(9):1890-7. doi: 10.1093/annonc/mdv242. Epub 2015 May 22.
  • BACKGROUND: Intergroup Exemestane Study (IES) was a randomised study that showed a survival benefit of switching adjuvant endocrine therapy after 2-3 years from tamoxifen to exemestane. PathIES aimed to assess the potential prognostic and predictive value of ERβ1 and ERβ2 expression in primary tum
  • PMID 26002610


  • 症例報告 エベロリムスとエキセメスタンが奏効した濃厚な前治療歴を有する転移性乳癌の1例
  • 西口 春香,尾浦 正二,吉増 達也 [他]
  • 和歌山医学 66(1), 7-9, 2015-03
  • NAID 40020434186
  • Exemestane(EXE)術前6か月間投与により病理学的完全奏功(pCR)を得たER 陽性乳癌の1例
  • 戸塚 勝理,黒住 献,松本 広志,坪井 美樹,久保 和之,林 祐二,二宮 淳,武井 寛幸,大久保 文恵,永井 成勲,井上 賢一,大庭 華子,黒住 昌史,堀口 淳,竹吉 泉
  • The Kitakanto medical journal = 北関東医学 64(2), 228-228, 2014-05-01
  • NAID 120005429892
  • 術後7年目に癌性腹膜炎に続いて両側視神経転移を伴う髄膜播種を来した乳癌の1例
  • 久保 秀文,中須賀 千代,多田 耕輔,宮原 誠,長谷川 博康,原田 有彦
  • 山口医学 63(1), 25-30, 2014-02-01
  • … She received 6 cycles of paclitaxel every week, after which an aromatase inhibitor(exemestane)was administered for 5 years. …
  • NAID 120005435143


Exemestane (trade name Aromasin) is a drug used to treat breast cancer. It is a member of the class of drugs known as aromatase inhibitors. Some breast cancers require estrogen to grow. Those cancers have estrogen receptors (ERs), and are called ER-positive.
のサプライヤーのリストを取得する Exemestane と同等の製品を ... Gihi Chemicals Co., Ltd. ためのサプライヤです Exemestane. 私たちは、化学製品Methyl-1H-benzotriazole sodium saltを供給しています。


Buy Exemestane | Exemestane 25mg x 30ml product-IMR-Bottle_0003_EXEMESTANEExemestane | Steel Buildings UK - Steel Buy Exemestane | Buy Liquid ExemestaneExemestane (Aromasin) 25mg/ML @ 30MLExemestane - Wikipedia, the free